On Monday, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) was -4.36% drop from the session before settling in for the closing price of $11.0. A 52-week range for ORIC has been $3.90 – $14.93.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -15.32%. When this article was written, the company’s average yearly earnings per share was at 11.11%. With a float of $54.16 million, this company’s outstanding shares have now reached $97.28 million.
ORIC Pharmaceuticals Inc (ORIC) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ORIC Pharmaceuticals Inc stocks. The insider ownership of ORIC Pharmaceuticals Inc is 44.39%, while institutional ownership is 68.87%. The most recent insider transaction that took place on Oct 06 ’25, was worth 159,719. In this transaction Chief Financial Officer of this company sold 11,000 shares at a rate of $14.52, taking the stock ownership to the 48,317 shares. Before that another transaction happened on Oct 06 ’25, when Company’s PRESIDENT AND CEO sold 37,461 for $12.32, making the entire transaction worth $461,520. This insider now owns 531,419 shares in total.
ORIC Pharmaceuticals Inc (ORIC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 11.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.13% during the next five years compared to -15.32% drop over the previous five years of trading.
ORIC Pharmaceuticals Inc (NASDAQ: ORIC) Trading Performance Indicators
You can see what ORIC Pharmaceuticals Inc (ORIC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.73, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.61 in one year’s time.
Technical Analysis of ORIC Pharmaceuticals Inc (ORIC)
Compared to the last year’s volume of 1.17 million, its volume of 1.53 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 29.01%.
During the past 100 days, ORIC Pharmaceuticals Inc’s (ORIC) raw stochastic average was set at 26.01%, which indicates a significant increase from 5.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.82 in the past 14 days, which was higher than the 0.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.41, while its 200-day Moving Average is $9.40. Nevertheless, the first resistance level for the watch stands at $11.88 in the near term. At $13.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.98. If the price goes on to break the first support level at $9.78, it is likely to go to the next support level at $9.04. Now, if the price goes above the second support level, the third support stands at $7.68.
ORIC Pharmaceuticals Inc (NASDAQ: ORIC) Key Stats
There are 97,389K outstanding shares of the company, which has a market capitalization of 1.02 billion. As of now, sales total 0 K while income totals -127,850 K. Its latest quarter income was 0 K while its last quarter net income were -32,590 K.
